SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-048358
Filing Date
2007-06-18
Accepted
2007-06-19 08:29:47
Documents
4
Period of Report
2007-06-18
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-16884_28k.htm 8-K 39049
2 EX-99.1 a07-16884_2ex99d1.htm EX-99.1 245794
3 EX-99.2 a07-16884_2ex99d2.htm EX-99.2 11286
4 GRAPHIC g168842koi001.jpg GRAPHIC 2936
  Complete submission text file 0001104659-07-048358.txt   302347
Mailing Address ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address ONE MEDIMMUNE WAY GAITHERSBURG MD 20878 301-398-0000
MEDIMMUNE INC /DE (Filer) CIK: 0000873591 (see all company filings)

IRS No.: 521555759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19131 | Film No.: 07927359
SIC: 2836 Biological Products, (No Diagnostic Substances)